Article info

PDF

Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: one year follow up
  1. Correspondence to:
    Dr E Kruithof, Department of Rheumatology, OK12IB, Ghent University Hospital, De Pintelaan 185, 9000 Gent, Belgium;
    elli.kruithof{at}rug.ac.be
View Full Text

Citation

Kruithof E, Van den Bosch F, Baeten D, et al
Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: one year follow up

Publication history

  • Accepted August 20, 2001
  • First published March 1, 2002.
Online issue publication 
March 01, 2002

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.